Chemical genetic analyses of quantitative changes in Cdk1 activity during the human cell cycle

Human Molecular Genetics

Volumn 22, Issue 14, 2013, Pages 2842-2851

  Gravells, Polly ^a   Tomita, Kazunori ^a,b   Booth, Alexander ^a,c   Poznansky, Joshua ^a   Porter, Andrew C G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1NMPP1; CYCLIN DEPENDENT KINASE 1; ENZYME INHIBITOR; PROTEIN INHIBITOR; RO 3306; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CHEMICAL GENETICS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; XENOPUS;

ANIMALS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; G2 PHASE; HUMANS; MITOSIS; PROTEIN KINASES; PYRAZOLES; PYRIMIDINES; XENOPUS; XENOPUS PROTEINS;

EID: 84880321463     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt133     Document Type: Article

References (54)

1. Goga, A., Yang, D., Tward, A.D., Morgan, D.O. and Bishop, J.M. (2007) Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat. Med., 13, 820-827.
2. Johnson, N., Li, Y.C., Walton, Z.E., Cheng, K.A., Li, D., Rodig, S.J., Moreau, L.A., Unitt, C., Bronson, R.T., Thomas, H.D. et al. (2011) Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition. Nat. Med., 17, 875-882.
3. Shapiro, G.I. (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol., 24, 1770-1783.
4. Wang, Q., Su, L., Liu, N., Zhang, L., Xu, W. and Fang, H. (2011) Cyclin dependent kinase 1 inhibitors: a review of recent progress. Curr. Med. Chem., 18, 2025-2043.
5. Zhao, X.F. and Gartenhaus, R.B. (2009) Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma. Expert Opin. Ther. Targets, 13, 1085-1093.
6. Enserink, J.M. and Kolodner, R.D. (2010) An overview of Cdk1-controlled targets and processes. Cell Div., 5, 11.
7. Malumbres, M. (2011) Physiological relevance of cell cycle kinases. Physiol. Rev., 91, 973-1007.
8. Stern, B. and Nurse, P. (1996) A quantitative model for the cdc2 control of S phase and mitosis in fission yeast. Trends Genet., 12, 345-350.
9. Coudreuse, D. and Nurse, P. (2010) Driving the cell cycle with a minimal CDK control network. Nature, 468, 1074-1079.
10. Bishop, A., Buzko, O., Heyeck-Dumas, S., Jung, I., Kraybill, B., Liu, Y., Shah, K., Ulrich, S., Witucki, L., Yang, F. et al. (2000) Unnatural ligands for engineered proteins: new tools for chemical genetics. Annu. Rev. Biophys. Biomol. Struct., 29, 577-606.
11. Ganuza, M., Saiz-Ladera, C., Canamero, M., Gomez, G., Schneider, R., Blasco, M.A., Pisano, D., Paramio, J.M., Santamaria, D. and Barbacid, M. (2012) Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion. EMBO J., 31, 2498-2510.
12. Larochelle, S., Pandur, J., Fisher, R.P., Salz, H.K. and Suter, B. (1998) Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activity. Genes Dev., 12, 370-381.
13. Hochegger, H., Takeda, S. and Hunt, T. (2008) Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat. Rev. Mol. Cell Biol., 9, 910-916.
14. Malumbres, M. (2005) Revisiting the 'Cdk-centric' view of the mammalian cell cycle. Cell Cycle, 4, 206-210.
15. Satyanarayana, A. and Kaldis, P. (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene, 28, 2925-2939.
16. Diril, M.K., Ratnacaram, C.K., Padmakumar, V.C., Du, T., Wasser, M., Coppola, V., Tessarollo, L. and Kaldis, P. (2012) Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc. Natl Acad. Sci. USA, 109, 3826-3831.
17. Ma, H.T., Tsang, Y.H., Marxer, M. and Poon, R.Y. (2009) Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Mol. Cell. Biol., 29, 6500-6514.
18. Porter, A.C. (2008) Preventing DNA over-replication: a Cdk perspective. Cell Div., 3, 3.
19. Davoli, T. and de Lange, T. (2011) The causes and consequences of polyploidy in normal development and cancer. Annu. Rev. Cell Dev. Biol., 27, 585-610.
20. Fox, D.T. and Duronio, R.J. (2013) Endoreplication and polyploidy: insights into development and disease. Development, 140, 3-12.
21. Hochegger, H., Dejsuphong, D., Sonoda, E., Saberi, A., Rajendra, E., Kirk, J., Hunt, T. and Takeda, S. (2007) An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells. J. Cell Biol., 178, 257-268.
22. Vassilev, L.T., Tovar, C., Chen, S., Knezevic, D., Zhao, X., Sun, H., Heimbrook, D.C. and Chen, L. (2006) Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl Acad. Sci. USA, 103, 10660-10665.
23. Berry, L.D. and Gould, K.L. (1996) Regulation of Cdc2 activity by phosphorylation at T14/Y15. Prog. Cell Cycle Res., 2, 99-105.
24. Coleman, T.R. and Dunphy, W.G. (1994) Cdc2 regulatory factors. Curr. Opin. Cell Biol., 6, 877-882.
25. Lindqvist, A., Rodriguez-Bravo, V. and Medema, R.H. (2009) The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J. Cell Biol., 185, 193-202.
26. Nurse, P. (1990) Universal control mechanism regulating onset of M-phase. Nature, 344, 503-508.
27. Domingo-Sananes, M.R., Kapuy, O., Hunt, T. and Novak, B. (2011) Switches and latches: a biochemical tug-of-war between the kinases and phosphatases that control mitosis. Philos. Trans. R. Soc. Lond. B Biol. Sci., 366, 3584-3594.
28. Ferrell, J.E. Jr (2002) Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol., 14, 140-148.
29. Blasina, A., Paegle, E.S. and McGowan, C.H. (1997) The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. Mol. Biol. Cell, 8, 1013-1023.
30. Gould, K.L. and Nurse, P. (1989) Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature, 342, 39-45.
31. Jin, P., Gu, Y. and Morgan, D.O. (1996) Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol., 134, 963-970.
32. Jin, P., Hardy, S. and Morgan, D.O. (1998) Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol., 141, 875-885.
33. Krek, W. and Nigg, E.A. (1991) Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J., 10, 3331-3341.
34. Ma, Y., Yuan, X., Wyatt, W.R. and Pomerening, J.R. (2012) Expression of constitutively active CDK1 stabilizes APC-Cdh1 substrates and potentiates premature spindle assembly and checkpoint function in G1 cells. PLoS One, 7, e33835.
35. Norbury, C., Blow, J. and Nurse, P. (1991) Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J., 10, 3321-3329.
36. Pomerening, J.R., Kim, S.Y. and Ferrell, J.E. Jr (2005) Systems-level dissection of the cell-cycle oscillator: bypassing positive feedback produces damped oscillations. Cell, 122, 565-578.
37. Pomerening, J.R., Ubersax, J.A. and Ferrell, J.E. Jr (2008) Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF. Mol. Biol. Cell., 19, 3426-3441.
38. Gupta, M., Itzhaki, J.E., Carpenter, A.J. and Porter, A.C.G. (2001) Rescue of a conditional CDC2 mutant human cell line with a CDC2 kinase that cannot be phosphorylated at Thr14 and Tyr15. Cell Biol. Int., 25, A24-A25.
39. Gupta, M., Trott, D. and Porter, A.C. (2007) Rescue of a human cell line from endogenous Cdk1 depletion by Cdk1 lacking inhibitory phosphorylation sites. J. Biol. Chem., 282, 4301-4309.
40. Itzhaki, J.E., Gilbert, C.S. and Porter, A.C. (1997) Construction by gene targeting in human cells of a 'conditional' CDC2 mutant that rereplicates its DNA. Nat. Genet., 15, 258-265.
41. Baxter, J. and Diffley, J.F. (2008) Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast. Mol. Cell, 30, 790-802.
42. Choi, S., Gamper, A.M., White, J.S. and Bakkenist, C.J. (2010) Inhibition of ATM kinase activity does not phenocopy ATM protein disruption:implications for the clinical utility of ATM kinase inhibitors. Cell Cycle, 9, 4052-4057.
43. Edgar, B.A. and Orr-Weaver, T.L. (2001) Endoreplication cell cycles: more for less. Cell, 105, 297-306.
44. Davoli, T., Denchi, E.L. and de Lange, T. (2010) Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell, 141, 81-93.
45. Laronne, A., Rotkopf, S., Hellman, A., Gruenbaum, Y., Porter, A.C. and Brandeis, M. (2003) Synchronization of interphase events depends neither on mitosis nor on cdk1. Mol. Biol. Cell, 14, 3730-3740.
46. Pines, J. (1999) Four-dimensional control of the cell cycle. Nat. Cell Biol., 1, E73-E79.
47. Arias, E.E. and Walter, J.C. (2007) Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells. Genes Dev., 21, 497-518.
48. Krasinska, L., Cot, E. and Fisher, D. (2008) Selective chemical inhibition as a tool to study Cdk1 and Cdk2 functions in the cell cycle. Cell Cycle, 7, 1702-1708.
49. Goldbeter, A. (1991) A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase. Proc. Natl Acad. Sci. USA, 88, 9107-9111.
50. Novak, B. and Tyson, J.J. (1993) Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J. Cell Sci., 106(Pt 4), 1153-1168.
51. Pomerening, J.R., Sontag, E.D. and Ferrell, J.E. Jr (2003) Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell Biol., 5, 346-351.
52. Harrison, J.C. and Haber, J.E. (2006) Surviving the breakup: the DNA damage checkpoint. Annu. Rev. Genet., 40, 209-235.
53. Sancar, A., Lindsey-Boltz, L.A., Unsal-Kacmaz, K. and Linn, S. (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem., 73, 39-85.
54. Carpenter, A.J. and Porter, A.C. (2004) Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line. Mol. Biol. Cell, 15, 5700-5711.